A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Area of Science:

• Urology
• Oncology
• Animal Models

Background:

• Developing reliable methods for inducing and monitoring bladder tumors in preclinical models is crucial for cancer research.
• The MB49 murine bladder cancer cell line, engineered to secrete human Prostate Specific Antigen (PSA), offers a unique tool for tracking tumor development.
• Accurate assessment of tumor implantation and growth is essential for evaluating therapeutic efficacy in animal studies.

Purpose of the Study:

• To describe a standardized protocol for generating bladder tumors in female C57BL/6J mice.
• To establish a method for confirming tumor implantation and monitoring tumor growth using urinary PSA levels.
• To highlight the advantages of PSA monitoring over other imaging techniques for bladder tumor assessment.

Main Methods:

• Anesthesia and surgical preparation of female C57BL/6J mice.
• Intravesical instillation of poly-L-lysine (PLL) followed by the MB49 cell line (1 x 10^5 cells/50 µL) using a 24 G IV catheter.
• Slow instillation rates (10 µL/20 s) to minimize vesicoureteral reflux and ensure uniform cell suspension to prevent clumping.

Main Results:

• The described technique efficiently induces bladder tumors in mice.
• Urinary PSA secretion serves as a reliable biomarker for monitoring tumor growth and confirming implantation.
• PSA monitoring allows for accurate differentiation between successfully implanted tumors and treatment failures, unlike end-point analysis alone.

Conclusions:

• This protocol provides a high-efficiency method for bladder tumor generation in mice.
• Urinary PSA monitoring is a superior method for tracking tumor progression and assessing treatment response in this model.
• The protocol enables reliable differentiation of therapeutic success from failed tumor implantation.